What causes increased echogenicity of fetal kidneys?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Increased Echogenic Fetal Kidneys

Increased echogenicity of fetal kidneys is associated with various pathological conditions, but when isolated with normal amniotic fluid volume, it often has a favorable outcome with normal renal function in infancy.

Common Causes

Genetic and Chromosomal Abnormalities

  • Aneuploidy (particularly trisomy 21, but also trisomy 18, trisomy 13, and monosomy X) can present with echogenic kidneys 1
  • Autosomal dominant polycystic kidney disease 2
  • Autosomal recessive polycystic kidney disease 2
  • Tuberous sclerosis with renal involvement 1

Structural Renal Abnormalities

  • Renal dysplasia (unilateral or bilateral) 3
  • Multicystic dysplastic kidney disease 3, 4
  • Hydronephrosis 3
  • Renal vein thrombosis 4

Infectious Causes

  • Congenital cytomegalovirus (CMV) infection 1
  • Toxoplasmosis 1
  • Renal candidiasis 4
  • Other TORCH infections (rubella, herpes, varicella, parvovirus) 1

Other Pathological Conditions

  • Perinatal asphyxia with secondary renal disease 4
  • Hemolytic-uremic syndrome 4
  • Intra-amniotic bleeding (following amniocentesis or fetal transfusion) 1

Prognostic Factors

Favorable Prognostic Indicators

  • Normal amniotic fluid volume is the most important positive prognostic factor 5
  • Isolated hyperechogenic kidneys without other renal or extrarenal abnormalities 5
  • Resolution or diminishing of echogenicity on follow-up ultrasound 6

Poor Prognostic Indicators

  • Oligohydramnios 3
  • Associated multiple renal tract abnormalities 5
  • Concomitant extrarenal abnormalities 5
  • Abnormal karyotype 5

Clinical Outcomes

  • In fetuses with isolated hyperechogenic kidneys and normal amniotic fluid, studies show:

    • Normal renal function in approximately 70-80% of cases 5
    • Complete resolution of echogenicity in about 50% of cases during postnatal follow-up 6
    • Diminished echogenicity in some cases with continued follow-up 6
  • In fetuses with hyperechogenic kidneys plus other abnormalities:

    • Higher rates of pregnancy termination, intrauterine death, or neonatal death 5
    • Increased risk of abnormal renal function requiring intervention 5

Clinical Implications

  • Detailed ultrasound evaluation should be performed to identify associated renal or extrarenal abnormalities 5
  • Assessment of amniotic fluid volume is crucial for prognostication 3, 5
  • Karyotype analysis should be considered, especially with other soft markers or abnormalities 1
  • Screening for congenital infections may be warranted 1
  • Postnatal follow-up with renal ultrasound and function tests is recommended 6, 5

Pitfalls to Avoid

  • Misinterpreting transient hyperechogenicity as permanent pathology - echogenicity may resolve postnatally 6
  • Failing to assess amniotic fluid volume, which is a critical prognostic indicator 5
  • Overlooking associated abnormalities that significantly impact prognosis 5
  • Not considering genetic evaluation when appropriate 1
  • Causing unnecessary parental anxiety when isolated hyperechogenic kidneys are found with normal amniotic fluid, as prognosis is generally good 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Increased renal echogenicity in the neonate.

Early human development, 1990

Research

Perinatal and infant outcome of fetuses with prenatally diagnosed hyperechogenic kidneys.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.